Published in Environ Health Perspect on December 01, 1996
Effect of maternal smoking on breast milk interleukin-1alpha, beta-endorphin, and leptin concentrations and leptin concentrations. Environ Health Perspect (2005) 1.42
Integrated defense system overlaps as a disease model: with examples for multiple chemical sensitivity. Environ Health Perspect (1998) 0.92
Cytokine network involvement in subjects exposed to benzene. J Immunol Res (2014) 0.76
A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature (1992) 9.96
Molecular cloning of the interleukin-1 beta converting enzyme. Science (1992) 4.19
Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Clin Invest (1986) 2.82
Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha. Proc Natl Acad Sci U S A (1990) 1.94
Regulation of very primitive, multipotent, hemopoietic cells by hemopoietin-1. Cell (1986) 1.89
Activation of interleukin-1 beta by a co-induced protease. FEBS Lett (1989) 1.83
Malignancies due to occupational exposure to benzene. Am J Ind Med (1985) 1.68
Benzene disposition in the rat after exposure by inhalation. Toxicol Appl Pharmacol (1979) 1.61
Recent advances in the metabolism and toxicity of benzene. Crit Rev Toxicol (1987) 1.50
Regulation of interleukin 1 production by mouse peritoneal macrophages. Effects of arachidonic acid metabolites, cyclic nucleotides, and interferons. J Biol Chem (1986) 1.30
Involvement of a calpain-like protease in the processing of the murine interleukin 1 alpha precursor. J Biol Chem (1991) 1.24
Interleukin-1. Ann N Y Acad Sci (1988) 1.07
Interleukin-1 regulation of hematopoietic growth factor production by human stromal fibroblasts. J Cell Physiol (1988) 0.99
Decreased content of the IL1 alpha processing enzyme calpain in murine bone marrow-derived macrophages after treatment with the benzene metabolite hydroquinone. Toxicol Lett (1994) 0.95
Interleukin 6 induces myeloid differentiation of a human biphenotypic leukemic cell line. Leuk Res (1992) 0.94
Benzene toxicity. Occup Med (1988) 0.93
Macrophage regulation of myelopoiesis is altered by exposure to the benzene metabolite hydroquinone. Toxicol Appl Pharmacol (1989) 0.93
Toxic effects of benzene and benzene metabolites on mononuclear phagocytes. Toxicol Appl Pharmacol (1988) 0.87
Metabolic activation of hydroquinone by macrophage peroxidase. Chem Biol Interact (1989) 0.87
High molecular weight kininogen is an inhibitor of platelet calpain. J Clin Invest (1986) 0.87
Amino acid sequence around the active site cysteine residue of calcium-activated neutral protease (CANP). FEBS Lett (1983) 0.86
Activation of bone marrow phagocytes following benzene treatment of mice. Environ Health Perspect (1989) 0.85
A morphological analysis of the short-term effects of benzene on the development of the hematological cells in the bone marrow of mice and the effects of interleukin-1 alpha on the process. Arch Toxicol (1995) 0.84
Decreased interleukin 1 production in aplastic anaemia. Br J Haematol (1989) 0.80
Decreased interleukin-1 production in aplastic anemia. Am J Med (1988) 0.80
The prevention of benzene-induced genotoxicity in mice by indomethacin. Mutat Res (1989) 0.78
Kinetics of inhibition of platelet calpain II by human kininogens. Biochem J (1990) 0.77
Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler Thromb Vasc Biol (2001) 1.86
Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg (1996) 1.51
Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant (2009) 1.42
Effects of coronary stenting on restenosis and occlusion after angioplasty of the culprit vessel in patients with recent myocardial infarction. Circulation (1997) 1.38
Surgical anatomy of the left lateral segment as applied to living-donor and split-liver transplantation: a clinicopathologic study. Ann Surg (2000) 1.13
Total vascular exclusion for major hepatectomy in patients with abnormal liver parenchyma. Arch Surg (1995) 1.05
Functional venous anatomy for right-lobe grafting and techniques to optimize outflow. Liver Transpl (2001) 1.05
Select utilization of obese donors in living donor liver transplantation: implications for the donor pool. Am J Transplant (2005) 1.04
Characteristics of coronary smooth muscle cells and adventitial fibroblasts. Circulation (2000) 0.92
Oxidative stress and lipid retention in vascular grafts: comparison between venous and arterial conduits. Circulation (2001) 0.90
Technical and logistical considerations of in situ split-liver transplantation for two adults: Part I. Creation of left segment II, III, IV and right segment I, V-VIII grafts. Liver Transpl (2001) 0.87
Failure patterns of cryopreserved vein grafts in liver transplantation. Transplantation (1996) 0.87
Surgical anatomy of the liver and its application to hepatobiliary surgery and transplantation. Semin Liver Dis (1994) 0.86
Benzene and its metabolite, hydroquinone, induce granulocytic differentiation in myeloblasts by interacting with cellular signaling pathways activated by granulocyte colony-stimulating factor. Stem Cells (1995) 0.85
Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration. Arterioscler Thromb Vasc Biol (1999) 0.84
Prevention of benzene-induced myelotoxicity by nonsteroidal anti-inflammatory drugs. Environ Health Perspect (1989) 0.82
Biliary complications of reduced-organ liver transplantation. Liver Transpl Surg (1998) 0.82
Regional differences in integrin expression: role of alpha(5)beta(1) in regulating smooth muscle cell functions. Circ Res (2001) 0.81
Decreased mortality from technical failure improves results in pediatric liver transplantation. Arch Surg (1996) 0.80
Improved outcome after intestinal transplantation at a single institution over 12 years. Transplant Proc (2004) 0.80
The prevention of benzene-induced genotoxicity in mice by indomethacin. Mutat Res (1989) 0.78
Induction therapy with interleukin-2 receptor antagonist after intestinal transplantation is associated with reduced acute cellular rejection and improved renal function. Transplant Proc (2004) 0.77
Platelet activating factor mediates interleukin-2-induced lung injury in the rat. J Clin Invest (1992) 0.77
Myofibroblast involvement in glycosaminoglycan synthesis and lipid retention during coronary repair. J Vasc Res (2000) 0.77
Infectious enteritis after intestinal transplantation: incidence, timing, and outcome. Transplant Proc (2004) 0.76
Prevalence of antiviral antibodies in workers handling wastewater and sludge. Virologie (1981) 0.76
Induction of granulocytic differentiation in a mouse model by benzene and hydroquinone. Environ Health Perspect (1996) 0.75
Nationally placed liver allografts: the devil is in the details. Am J Transplant (2012) 0.75
Protein C activity and postoperative metabolic liver function after liver transplantation. Transplant Proc (2012) 0.75
Angiofollicular lymph node hyperplasia (Castleman's disease). A pathological study of four cases. Morphol Embryol (Bucur) (1987) 0.75
[Indications, results and complications of splenectomy in 36 cases of chronic granulocytic leukemia (CGL)]. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna (1984) 0.75
Study of antibodies against viruses, chlamydiae, rickettsiae and Mycoplasma pneumoniae in children with respiratory diseases. Virologie (1982) 0.75
[Analysis of the evolution of morbidity caused by viral hepatitis in the S.R. of Rumania using a mathematical model]. Virologie (1977) 0.75
[30 cases of myeloid metaplasia and 5 cases of acute leukemia in a group of 200 cases of polycythemia vera]. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna (1984) 0.75
Special types of malignant lymphomas limited to intrathoracic sites. Arch Anat Cytol Pathol (1987) 0.75
Statistical studies on the epidemiology of human congenital malformations. Implications of maternal virus infections. Virologie (1983) 0.75
Benzene-induced bone marrow cell depression caused by inhibition of the conversion of pre-interleukins-1alpha and -1beta to active cytokines by hydroquinone, a biological reactive metabolite of benzene. Adv Exp Med Biol (1996) 0.75
[Etiopathogenetic considerations on a case of cleidocranial dysostosis]. Stud Cercet Endocrinol (1972) 0.75
[Temporary changes and permanent changes in the erythrocyte blood-group antigens in malignant hemopathies]. Rom J Intern Med (1997) 0.75
Variation of correlation coefficient among aging and certain biological variables in man. Rom J Physiol (1997) 0.75
[The staging of chronic lymphatic leukemia. Its prognostic value and therapeutic implications]. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna (1988) 0.75
Isolation of parainfluenza virus type 3 from an infant with meningoencephalitis. Virologie (1981) 0.75
Stochastic model of the evolution of viral hepatitis morbidity. Virologie (1981) 0.75
Contribution to the study of the multidimensional variational network of the human gerontogenesis. Rom J Physiol (1997) 0.75
Evaluation of the prematurity risk on the ground of severity scores reflecting the action of different factors, maternal virus infection included. Virologie (1984) 0.75
[Prognostic factors in chronic granulocytic leukemia]. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna (1984) 0.75
The action on mumps virus of several preparations obtained from human milk. Preliminary note. Virologie (1983) 0.75